XSHE
300239
Market cap483mUSD
Jul 16, Last price
5.89CNY
1D
0.17%
1Q
18.04%
Jan 2017
-27.10%
IPO
26.51%
Name
Baotou Dongbao Bio-Tech Co Ltd
Chart & Performance
Profile
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, production, and sale of gelatin and collagen products in the People's Republic of China and internationally. It offers food additive and pharmaceutical gelatin, as well as collagen peptide. The company was founded in 1997 and is based in Baotou, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 974,512 3.30% | 943,397 54.11% | |||||||
Cost of revenue | 789,005 | 763,912 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 185,508 | 179,485 | |||||||
NOPBT Margin | 19.04% | 19.03% | |||||||
Operating Taxes | 17,121 | 16,211 | |||||||
Tax Rate | 9.23% | 9.03% | |||||||
NOPAT | 168,386 | 163,274 | |||||||
Net income | 119,885 9.55% | 109,437 199.96% | |||||||
Dividends | (21,283) | (3,562) | |||||||
Dividend yield | 0.56% | 0.08% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 5,884 | 43,088 | |||||||
Long-term debt | 462,823 | 152,000 | |||||||
Deferred revenue | 45,157 | 48,667 | |||||||
Other long-term liabilities | 10,000 | 10,000 | |||||||
Net debt | (304,432) | (228,381) | |||||||
Cash flow | |||||||||
Cash from operating activities | 199,394 | 195,318 | |||||||
CAPEX | (132,242) | ||||||||
Cash from investing activities | (130,411) | ||||||||
Cash from financing activities | 305,869 | 175,083 | |||||||
FCF | 94,464 | 12,333 | |||||||
Balance | |||||||||
Cash | 748,691 | 356,112 | |||||||
Long term investments | 24,447 | 67,356 | |||||||
Excess cash | 724,413 | 376,299 | |||||||
Stockholders' equity | 1,173,544 | 1,121,295 | |||||||
Invested Capital | 1,692,644 | 1,618,299 | |||||||
ROIC | 10.17% | 10.63% | |||||||
ROCE | 7.58% | 8.89% | |||||||
EV | |||||||||
Common stock shares outstanding | 611,972 | 593,603 | |||||||
Price | 6.23 -16.93% | 7.50 6.38% | |||||||
Market cap | 3,812,587 -14.36% | 4,452,022 11.99% | |||||||
EV | 3,743,287 | 4,450,987 | |||||||
EBITDA | 267,472 | 265,000 | |||||||
EV/EBITDA | 14.00 | 16.80 | |||||||
Interest | 5,373 | 7,628 | |||||||
Interest/NOPBT | 2.90% | 4.25% |